Skip to main content
Joost Kluiver
dr.

I have a central role in all research projects focusing on the role of noncoding RNAs. My main aim is to understanding how small and long non-coding RNAs contribute to the pathogenesis of B-cell lymphoma. Ongoing studies include MYC-regulated miRNAs and lncRNAs, as well as miRNA-lncRNA interactions and the role of circular RNAs. We apply state-of-the-art methodology including AGO2-RIP, RNA-FISH and gain- and loss-of-function screens using shRNA and CRISPR-Cas technology.

HemaSphere (Journal)

Academic Editor

Period Apr-2025 → Apr-2028
Type of journal Journal
ISSN 2572-9241
Degree of Recognition International
HemaSphere (Journal)

Academic Editor

Period Apr-2025 → Apr-2028
Type of journal Journal
ISSN 2572-9241
Degree of Recognition International
Dutch Society for Pathology (NVVP) (External organisation)

Member of the Dutch Society of Pathology (NVVP) working group soft tissue tumours and member of the expert group on molecular diagnostics 

Period Mar-2022 → …
Held at Dutch Society for Pathology (NVVP)
Degree of Recognition National
Dutch Society for Pathology (NVVP) (External organisation)

Member of the Dutch Society of Pathology (NVVP) working group soft tissue tumours and member of the expert group on molecular diagnostics 

Period Mar-2022 → …
Held at Dutch Society for Pathology (NVVP)
Degree of Recognition National
Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON) (External organisation)

Member of the HOVON (Stichting Hemato-Oncologie voor Volwassenen Nederland) working group on Lymphoma

Period Jun-2022 → …
Held at Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Netherlands
Degree of Recognition National